Effect of pidotimod combined with Yanhuning on children with refractory Mycoplasma pneumonia clinical symptoms and immune function

VernacularTitle:匹多莫得联合炎琥宁对难治性支原体肺炎患儿的免疫功能与临床症状的影响
Author: Guijiao YE ; Shuying YAO ; Ying XU
Keywords: pidotimod; yanhuning; azithromycin refractory mycoplasma pneumonia
From: Chinese Journal of Biochemical Pharmaceutics 2017;37(6):246-248
CountryChina
Language:Chinese
Abstract: Objective To investigate the the curative effect of pidotimod combined with Yanhuning for children with refractory mycoplasma pneumonia(RMPP).Methods90 patients with RMPP from January 2013 to January 2015in shengzhou maternal and child health care hospital were divided into 3 groups, including Yanhuning group(A group), azithromycin combined with Yanhuning group(B group)and pidotimod combined with Yanhuning group(C group).And the total effective rate, the clinical symptoms, immune function parameters were analyzed.ResultsThe regulation of immune function in C group was more significant than that in A group and B group, the prognosis was better, and the repeated times and continuous time were decreased (P<0.05).ConclusionPidotimod combined with Yanhuning treatment of RMPP can regulate the immune function of children, improve clinical symptoms, it is worthy of popularization.